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Abstract
Fucans, a family of sulfated polysaccharides present in brown sea-
weed, have several biological activities. Their use as drugs would
offer the advantage of no potential risk of contamination with viruses
or particles such as prions. A fucan prepared from Spatoglossum
schröederi was tested as a possible inhibitor of cell-matrix interac-
tions using wild-type Chinese hamster ovary cells (CHO-K1) and the
mutant type deficient in xylosyltransferase (CHO-745). The effect of
this polymer on adhesion properties with specific extracellular matrix
components was studied using several matrix proteins as substrates for
cell attachment. Treatment with the polymer inhibited the adhesion of
fibronectin to both CHO-K1 (2 x 105) and CHO-745 (2 x 105 and 5 x
105) cells. No effect was detected with laminin, using the two cell
types. On the other hand, adhesion to vitronectin was inhibited in
CHO-K1 cells and adhesion to type I collagen was inhibited in CHO-
745 cells. In spite of this inhibition, the fucan did not affect either cell
proliferation or cell cycle. These results demonstrate that this polymer
is a new anti-adhesive compound with potential pharmacological
applications.
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Introduction
Fucan is a term used to define a family of
L-fucose-containing sulfated polysaccharides
with extremely variable molecular weights.
They are extracted from the extracellular
matrix of brown seaweed (1), the jelly coat
of sea urchin eggs (1), and the body wall of
the sea cucumber (2).
Since the first description of the fucan
from algae, these polysaccharides have been
tested for biological activities in different
mammalian systems. Alga fucans have anti-
viral (3), anti-ulcer and anti-adhesion activ-
ity (4), anticoagulant activity (1,5), anti-in-
flammatory activity, and antiproliferative and
antitumoral properties. They are inhibitors
of vascular smooth muscle cell and fibro-
blast proliferation and can block sperm-egg
binding in several species (6). The structures
of these fucans vary among species and some-
times among different parts of the plant (7).
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On the other hand, in contrast to animal
fucans, alga fucans have portions of other
neutral sugars and uronic acids in addition to
sulfate and fucose in their structures. This
complexity led Grauffel et al. (5) to propose
that the chemical composition of the differ-
ent polysaccharides may vary according to
the method of extraction. Thus, each new
fucan purified is a unique compound with
unique structural features and thus a poten-
tial new drug.
Structural features of fucans
The structural characteristics of sulfated
fucans responsible for all these biological
activities have not been determined and con-
sequently the relationships between struc-
tural and biological activities have not been
clearly established. Most of the difficulties
for these studies arise from the fact that these
compounds are highly heterogeneous poly-
saccharides which give complex nuclear mag-
netic resonance (NMR) spectra with broad
signals hampering resolution (1). In fact, for
these plant polysaccharides even high-field
NMR is of limited value, and complete de-
scriptions of their structures are not avail-
able at present (2). However, meaningful
structural studies using NMR are possible
with relative low molecular weight (LMW)
fucans that have been prepared by several
methods such as acid hydrolysis of high
molecular weight (HMW) fucans (8,9) or
extration from brown seaweeds (10).
Studies with LMW fucans obtained by
chemical hydrolysis of HMW fucans have
demonstrated that 3- and/or 4-linked fucose
residues are always present, sulfation at the
2 and 4 positions can also be identified in
these polymers and their biological activities
are apparently related not only to molecular
weight and sulfation, but also the quantity
and position of the sulfated residues in the
compound (1,6,8). Recently, Nagaoka et al.
(4), using data from partial acid hydrolysis,
methylation and NMR analysis, proposed
the average structure of a 56-kDa fucan.
Although chemical hydrolysis is important
to determine the structure of fucans, it can
cause structural alterations such as debranch-
ing or desulfation. Only enzymatic methods
can cleave glycosidic linkages specifically
without modifying the structural units pre-
sent in the original polysaccharide. How-
ever, no commercial endofucosidases are
available. The extraction of LMW fucans
from brown seaweed, which have biological
activity, would be very important to deter-
mine the structure/biological activity rela-
tionships of fucans.
Dietrich et al. (7) have fractionated fucans
from three types of brown seaweeds using
the same methodology for the characteriza-
tion and quantitation of the different classes
of glycosaminoglycans (11). They have dem-
onstrated that these seaweeds contain three
main fucans with distinct electrophoretic mo-
bilities which were named A, B and C ac-
cording to their relative mobility. A 21-kDa
LMW fucan with mobility equal to that of
fucan A was extracted from the brown algae
Spatoglossum schröederi (10) using the same
methodology. This fucan is composed of a
core of ß (1-3) glucuronic acid-containing
oligosaccharide of 4.5 kDa with branches at
C-4 of fucose chains a (1-3) linked. The
fucose is mostly substituted at C-4 with sul-
fate groups and at C-2 with chains of ß (1-4)
xylose, which, in turn, is also partially sul-
fated. Recently, using this methodology we
have also purified a fucan with the mobility
of fucan B from the same alga (12). This
compound differs from the A fucan by the
presence of significant amounts of galactose.
Here we describe the effect of this fucan
on cell proliferation, cell cycle and adhe-
siveness of both wild-type Chinese hamster
ovary cells (CHO-K1) and xylosyltrans-
ferase-deficient mutant (CHO-745) to sev-
eral extracellular matrix proteins. In the mu-
tant the synthesis of both heparan and chon-
droitin sulfates is diminished. The glycosami-
noglycans synthesized by mutant 745 were
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about 5% of those produced by wild-type
cells (13). CHO-K1 cells are tumorigenic
whereas CHO-745 mutant cells are not (13).
Cell proliferation and fucans
Cell proliferation is a physiological pro-
cess regulated by a broad range of growth
factors and cytokines such as fibroblast
growth factor. It has been reported that an-
ionic polysaccharides such as heparin and
fucans, due to their highly negative charge
bind to several growth factors (6) and this
binding is thought to have an important regu-
latory role (either stimulatory or inhibitory)
on cell proliferation.
Fucans were shown to be anti-angiogenic
and to inhibit smooth muscle (14) and endo-
thelial cell growth (15). In addition, LMW
fucan affects smooth muscle cell growth in a
time- and dose-dependent, reversible and
nontoxic fashion. It acts after internaliza-
tion, arresting cells at the G0/G1 phase of the
cell cycle (14).
The growth of several tumor cells is af-
fected by fucans (16,17). Studies performed
with the non-small-cell human bronchopul-
monary carcinoma line (NSCLC-N6) have
shown that an HMW fucan exhibits an inhib-
itory effect both in vitro and in vivo (18).
Fibroblasts (CCL 39) show 80% inhibition
of proliferation in the presence of LMW
fucan at a concentration of 1000 µg/ml. This
inhibition does not exceed 50% of human
colon adenocarcinoma cells and has no de-
tectable effect on lymphocytic leukemia
(P388) or human breast adenocarcinoma
(MCF7, MCF7ras). This action is reversible
and is not related to any modification of the
cell distribution during various phases of the
cell cycle (17). However, it is related to the
chemical structure of the osidic units and to
the extent of sulfation of the polymer.
The present studies with LMW B fucan
from S. schröederi against tumorigenic CHO-
K1 cells and nontumorigenic CHO-745 cells
did not show any modification of the cell
Figure 1. Thymidine incorporation and proliferation of CHO cells in the presence of fucan B
from Spatoglossum schröederi. A, Thymidine incorporation into CHO cells in the presence
of fucan. CHO cells were maintained in F-12 medium supplemented with 10% FCS at
37oC, 2.5% CO2. For the incorporation of [3H]-thymidine, quiescent cultures were incu-
bated with [3H]-thymidine (0.25 µCi/ml) for the times indicated and radioactivity was
determined by scintillation counting. Data  are reported as the mean ± SD of four determi-
nations. FUC - Fucan B. B, Effect of different fucan concentrations on the growth of CHO
cells. Growth-arrested cells were released from the G0 phase by the addition F-12 medium
plus 10% FCS in the absence (control) or in the presence of the indicated concentrations of
fucan. The initial cell number was 3 x 105 cells/plate. After incubation at 37oC for 5 days in
a 2.5% CO2 atmosphere, the cells (in triplicate plates) were harvested after “viocase”
treatment and cell number was determined. Values are reported as the mean ± SD of
triplicate determinations.
distribution during the phases of the cell
cycle (Figure 1A) when quiescent cultures
of both cell lines were incubated with [3H]-
thymidine (0.25 µCi/ml), 10% FCS and fucan
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(100 µg/ml). Moreover, no inhibitory or
stimulatory effects on cell proliferation were
observed using fucan concentrations of 10 to
200 µg/ml (Figure 1B). However, anti-adhe-
sive effects were observed with the same
concentrations of fucan.
Anti-adhesive fucans
Cell adhesion has been shown to involve
interactions between substrate components
and cell surface molecules; however, knowl-
edge concerning the detailed biochemistry
of these events is limited. This is because
adhesion is a complex process involving
several steps including initial attachment,
mobilization of the cytoskeleton and subse-
quent spreading. These steps are likely to be
mediated by different sets of molecules and
signals. In addition, different cell types re-
spond to a given substrate in different ways.
The detachment of arrested tumor cells
and their recirculation out of a given organ
site are important aspects of metastasis, but
this does not necessarily indicate that im-
plantation in the microcirculation and meta-
static colonization will follow. Mechanical
arrest, stable attachment and adhesion of
malignant cells to normal tissues may be
necessary to prevent spontaneous detach-
ment, recirculation and eventual cell death
by continued circulatory mechanical trauma.
Tumor cells tend to migrate to the basement
membranes where they adhere more strongly.
In fact, the invasion of tumor cells through
basement membranes and adhesion to ma-
trix proteins (laminin, fibronectin, vitronec-
tin, etc.) are the crucial steps in the formation
of metastasis. Thus, drugs inhibiting cell
adhesion should theoretically prevent the
formation of metastasis.
Soeda et al. (19) reported an inhibition of
Lewis lung carcinoma cell attachment to
laminin in the presence of HMW fucans;
however, no effect was detected for type IV
collagen or fibronectin. An HMW fucan from
Sargassum stenophyllum blocked attachment
of the carcinoma cells to laminin, vitronectin
and type IV collagen by 86.4, 53.6 and 28.0%,
respectively (20). Chemical analysis has
shown that sulfates and uronic acid groups
are critical for the anti-adhesive activity of
this fucan. LMW fucans specifically inhibit
the adhesion of McCoy fibroblast cells and
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Figure 2. Effect of fucan on CHO cell adhesion to different matrix proteins. CHO cells, 2 x
105 or 5 x 105, in 100 µl or 250 µl of cell suspension, respectively, were seeded on plastic
plates coated with extracellular matrix proteins. The cells and fucan (100 µg/ml) were added
simultaneously to 500 µl of F-12 medium containing 100 µg/ml fucan. CHO cells were
stained with crystal violet. CHO cells that adhered to the surface at the indicated times were
used as a measure of cell adhesion. The data are reported relative to the values in the
absence of fucan, as means ± SD of four determinations. LN - laminin; FN - fibronectin;
VN - vitronectin; Col I - type I collagen.
625
Braz J Med Biol Res 34(5) 2001
Anti-adhesive fucan
decrease thrombospondin production in
COLO 320 DM cells (17).
In the present study, the ability of the
wild-type and mutant CHO cells to interact
with exogenous proteins, e.g., fibronectin
(FN), laminin (LN), vitronectin (VN) and
type I collagen (Col I) in the presence of the
LMW fucan (100 µg/ml) from S. schröederi
was tested in a cell adhesion assay.
Cell attachment is a time-dependent re-
action which is also affected by the concen-
tration of cell surface receptors and ligands.
Thus, we have examined the attachment of
CHO cells to wells coated with matrix pro-
teins (10 µg/ml) during three different peri-
ods of time with two different cell concen-
trations, i.e., 2 x 105 and 5 x 105 (Figure 2).
Regardless of the number of wild-type and
mutant CHO cells, fucan did not show anti-
adhesive activity when laminin was used as
the substrate. However, the fucan presented
an anti-adhesive effect on 2 x 105 wild-type
CHO cells when vitronectin was used as a
substrate and on 2 x 105 745 mutant CHO
cells when type I collagen was used as  a
substrate. No effect was observed with 5 x
105 cells in either case.
It is interesting to note that when fibro-
nectin was used as the substrate, fucan acted
as an anti-adhesive molecule with both cell
types at 2 x 105 cell concentration. This is the
first report of a fucan inhibiting cell attach-
ment to fibronectin. We are presently inves-
tigating other possible activities of this fucan
that produce physiological alterations in CHO
cells.
The glycosaminoglycans heparin and hep-
aran have demonstrated anti-adhesive activ-
ity on several cell lines. Since polysaccha-
rides are extracted from animal tissues, they
are potentially contaminated with viruses or
unconventional particles such as those pre-
sent in bovine spongiform encephalopathy.
Because the fucans can mimic the effects of
heparin and heparan sulfate they may be safe
substitutes of these glycosaminoglycans as
pharmacological agents.
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